Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2013; 34(04): 323-326
DOI: 10.4103/0971-5851.125259
CASE REPORT

Human immunodeficiency virus Infection in a patient of chronic myelogenous leukemia

Vijay B. Tuljapurkar
Department of Clinical Research, Shri Siddhivinayak Ganapati Cancer Hospital, Miraj, Maharashtra, India
,
Uday A. Phatak
Medical Oncology Unit II, Miraj, Maharashtra, India
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints

Abstract

Association of Cancer and HIV infection is seen in practice. Commonly observed cancer in HIV infected patients are Non-Hodgkin′s Lymphoma, cervical cancer and Kaposi Sarcoma, Coexistent Chronic Myelogenous Leukemia (CML) and HIV infection are rare. We report a case where these two diseases were found in a patient and were treated with a single agent Hydroxyurea.

Keywords

CML - HIV - Hydroxyurea


Publication History

Article published online:
19 July 2021

© 2013. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Schlaberg R, Fisher JG, Flamm MJ, Murty VV, Bhagat G, Alobeid B. Chronic myeloid leukemia and HIV-infection. Leuk Lymphoma 2008;49:1155-60.
  • 2 Verneris MR, Tuel L, Seibel NL. Pediatric HIV infection and chronic myelogenous leukemia. Pediatr AIDS HIV Infect 1995;6:292-4.
  • 3 Webb MJ, Barrett CL, Pretorius C, van Jaarsveld MF, Louw VJ. Chronic myeloid leukaemia and human immunodeficiency virus (HIV) infection. Int J Hematol 2012;95:556-63.
  • 4 Setty BA, Hayani KC, Sharon BI, Schmidt ML. Prolonged chronic phase of greater than 10 years of chronic myelogenous leukemia in a patient with congenital human immunodefeciency virus infection. Pediatr Blood Cancer 2009;53:658-60.
  • 5 Mahon FX, Nabera CB, Pellegrin JL, Cony-Makhoul P, Leng B, Bernard P, et al. Improving the cytogenetic response to interferon alpha by Zidovudine (AZT) in an HIV-positive chronic myelogenous leukemia patient. Leuk Lymphoma 1997;26:205-7.
  • 6 Frank I, Bosch RJ, Fiscus S, Valentine F, Flexner C, Segal Y, et al. Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: A randomized, placebo-controlled trial, ACTG 307. AIDS Res Hum Retroviruses 2004;20:916-26.
  • 7 McCarthy WF, Gable J, Lawrence J, Thompson M, AIDS Research Consortium of Atlanta ASD Investigators. A retrospective study to determine if hydroxyurea augmentation of antiretroviral drug regimens that contain ddI and/or d4T increases the risk of developing peripheral neuropathy in HIV-1 infected individuals. Pharmacoepidemiol Drug Saf 2000;9:49-53.
  • 8 Kumar L. Chronic myelogenous leukaemia (CML): An update. Natl Med J India 2006;19:255-63.
  • 9 Bakshi RP, Hamzeh F, Frank I, Eron JJ Jr, Bosch RJ, Rosenkranz SL, et al. Effect of hydroxyurea and dideoxyinosine on intracellular 3′-deoxyadenosine-5′-triphosphate concentrations in HIV-infected patients. AIDS Res Hum Retroviruses 2007;23:1360-5.